Tyra Biosciences, Inc. (TYRA) Insider Trading
Directors, officers and holders of more than 10% of TYRA report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 123 transactions on file: 2 with code P, 14 with code S and 34 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Fuhrman Alan | Chief Financial Officer | A Award | 951 | $9.13 | $8,682 |
| Sep 15, 2026 | Rueb Yuliya | Vice President, Finance (PAO) | A Award | 2,925 | $9.13 | $26,702 |
| Sep 15, 2026 | Harris Todd | President and CEO | A Award | 864 | $9.13 | $7,887 |
| Sep 15, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | P Purchase | 9,078,529 | $22.03 | $199,990,915 |
| Sep 9, 2026 | Verjee Rehan | Director | P Purchase | 972 | $20.58 | $20,000 |
| May 28, 2026 | Simson Jake | Director | A Award | 13,160 | Not measured | Not measured |
| May 28, 2026 | MORE ROBERT J | Director | A Award | 13,160 | Not measured | Not measured |
| May 28, 2026 | Moran Susan | Director | A Award | 13,160 | Not measured | Not measured |
| May 28, 2026 | Verjee Rehan | Director | A Award | 13,160 | Not measured | Not measured |
| May 28, 2026 | Gulfo Adele M. | Director | A Award | 13,160 | Not measured | Not measured |
| May 28, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | A Award | 13,160 | Not measured | Not measured |
| May 28, 2026 | Rothenberg Stephen Michael | Director | A Award | 13,160 | Not measured | Not measured |
| May 5, 2026 | Fuhrman Alan | Chief Financial Officer | A Award | 67,000 | Not measured | Not measured |
| May 5, 2026 | Harris Todd | President and CEO | A Award | 79,000 | Not measured | Not measured |
| May 5, 2026 | Warner Douglas J | Chief Medical Officer | A Award | 25,000 | Not measured | Not measured |
| May 5, 2026 | Harris Todd | President and CEO | A Award | 265,000 | Not measured | Not measured |
| May 5, 2026 | Ashar Bhavesh | Chief Operating Officer | A Award | 50,295 | Not measured | Not measured |
| May 5, 2026 | Rueb Yuliya | Vice President, Finance (PAO) | A Award | 28,000 | Not measured | Not measured |
| May 5, 2026 | Rueb Yuliya | Vice President, Finance (PAO) | A Award | 8,333 | Not measured | Not measured |
| May 5, 2026 | Ashar Bhavesh | Chief Operating Officer | A Award | 15,013 | Not measured | Not measured |
| May 5, 2026 | Fuhrman Alan | Chief Financial Officer | A Award | 20,000 | Not measured | Not measured |
| May 5, 2026 | Warner Douglas J | Chief Medical Officer | A Award | 85,000 | Not measured | Not measured |
| Apr 16, 2026 | Dable Habib J | Director | A Award | 44,400 | Not measured | Not measured |
| Mar 26, 2026 | KAPLAN GILLA | Director | D Disposition | 53,172 | $37.75 | $2,007,153 |
| Mar 26, 2026 | KAPLAN GILLA | Director | M Exercise | 53,172 | $2.25 | $119,637 |
| Mar 26, 2026 | KAPLAN GILLA | Director | M Exercise | 53,172 | Not measured | Not measured |
| Mar 25, 2026 | KAPLAN GILLA | Director | S Sale | 14,295 | $36.97 | $528,506 |
| Mar 25, 2026 | KAPLAN GILLA | Director | M Exercise | 14,295 | $2.25 | $32,164 |
| Mar 25, 2026 | KAPLAN GILLA | Director | M Exercise | 14,295 | Not measured | Not measured |
| Mar 13, 2026 | Harris Todd | President and CEO | A Award | 1,463 | $9.13 | $13,356 |
| Mar 13, 2026 | Fuhrman Alan | Chief Financial Officer | A Award | 1,376 | $9.13 | $12,562 |
| Feb 12, 2026 | Bensen Daniel | Chief Discovery Officer | S Sale | 5,872 | $33.37 | $195,929 |
| Feb 12, 2026 | Bensen Daniel | Chief Discovery Officer | S Sale | 2,128 | $31.50 | $67,036 |
| Jan 12, 2026 | Bensen Daniel | Chief Discovery Officer | S Sale | 6,983 | $28.44 | $198,610 |
| Jan 12, 2026 | Bensen Daniel | Chief Discovery Officer | S Sale | 1,017 | $29.08 | $29,575 |
| Dec 19, 2025 | MORE ROBERT J | Director | S Sale | 10,000 | $25.00 | $250,000 |
| Dec 12, 2025 | Bensen Daniel | Chief Discovery Officer | S Sale | 8,000 | $22.64 | $181,159 |
| Dec 1, 2025 | Ashar Bhavesh | Chief Operating Officer | A Award | 300,000 | Not measured | Not measured |
| Nov 21, 2025 | MORE ROBERT J | Director | S Sale | 246,871 | $20.25 | $5,000,026 |
| Nov 19, 2025 | Bensen Daniel | Chief Discovery Officer | S Sale | 49,956 | $16.32 | $815,297 |
| Nov 18, 2025 | Bensen Daniel | Chief Discovery Officer | S Sale | 75,633 | $16.07 | $1,215,627 |
| Nov 17, 2025 | Bensen Daniel | Chief Discovery Officer | S Sale | 18,572 | $16.11 | $299,191 |
| Nov 17, 2025 | Bensen Daniel | Chief Discovery Officer | S Sale | 1,500 | $17.07 | $25,607 |
| Nov 14, 2025 | Bensen Daniel | Chief Discovery Officer | S Sale | 110,228 | $16.02 | $1,765,489 |
| Nov 13, 2025 | Bensen Daniel | Chief Discovery Officer | S Sale | 1,111 | $16.00 | $17,780 |
| Sep 15, 2025 | Fuhrman Alan | Chief Financial Officer | A Award | 701 | $9.13 | $6,399 |
| Aug 7, 2025 | Bensen Daniel | Chief Discovery Officer | A Award | 170,000 | Not measured | Not measured |
| Aug 7, 2025 | Fuhrman Alan | Chief Financial Officer | A Award | 170,000 | Not measured | Not measured |
| Aug 7, 2025 | Harris Todd | President and CEO | A Award | 570,000 | Not measured | Not measured |
| Aug 7, 2025 | Warner Douglas J | Chief Medical Officer | A Award | 200,000 | Not measured | Not measured |
The full Form 4 history is on the TYRA company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.